Physicians
Overview
Cellvizio system
Education
Reimbursement
GastroEnterology
Barrett’s Esophagus
Pancreatic Cysts
Gastric Disease
Inflammatory Bowel Diseases
Irritable Bowel Syndrome
Bilio-Pancreatic Strictures
Colorectal Lesions
Pulmonology
Lung Nodules
Covid-19
Urology
Investors
About us
Our story
Team
Board of Directors
Leadership
Join Us
Press Coverage
Commercial Network
News & events
US
INT
FR
US
INT
FR
Contact
Search
Search
News - Cellvizio
-
Mar 20, 2019
Financial results for the full year ended December 31, 2018
READ THE COMPLETE PRESS RELEASE
You might also like to read
NEWS - Cellvizio
Jul 11, 2022
Tasly Pharmaceuticals and Mauna Kea Technologies Announce Joint Venture and Licensing Agreements
Discover
NEWS - Cellvizio
May 26, 2020
Cellvizio® Endorsed by the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) as a Safe and Effective Diagnostic Tool
Discover
NEWS - Cellvizio
Mar 3, 2020
Mauna Kea Technologies Receives FDA Clearance and CE Marking For Its Next-Generation Cellvizio® Platform
Discover
